sotax 80mg tablets
codal-synto limited (0000010484) 21 constantinoupoleos str., limassol, 3011, 51785 (3508) - sotalol hydrochloride - tablets - 80mg - sotalol hydrochloride (0000959240) 80mg - sotalol
sotalol hydrochloride tablet
ncs healthcare of ky, inc dba vangard labs - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride 80 mg - oral sotalol hydrochloride is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgment of the physician are life-threatening. because of the proarrhythmic effects of sotalol (see warnings ), including a 1.5 to 2% rate of torsade de pointes or new vt/vf in patients with either nsvt or supraventricular arrhythmias, its use in patients with less severe arrhythmias, even if the patients are symptomatic, is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of sotalol treatment or increasing doses, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. the response to treatment should then be evaluated by a suitable method (e.g., pes or holter monitoring) prior to continuing the patient on chronic therapy. various approaches have been used to determine the response to antiarrhythmic therapy, includi
sotalol hydrochloride tablet
proficient rx lp - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride 80 mg - oral sotalol hydrochloride is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgment of the physician are life-threatening. because of the proarrhythmic effects of sotalol (see warnings ), including a 1.5 to 2% rate of torsade de pointes or new vt/vf in patients with either nsvt or supraventricular arrhythmias, its use in patients with less severe arrhythmias, even if the patients are symptomatic, is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of sotalol treatment or increasing doses, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. the response to treatment should then be evaluated by a suitable method (e.g., pes or holter monitoring) prior to continuing the patient on chronic therapy. various approaches have been used to determine the response to antiarrhythmic therapy, includi
pestikal la sota spf
genera d.d., svetonedeljska cesta 2, kalinovica, 10436 rakov potok, hrvatska - lentogeni živi virus newcastleske bolesti, soj la sota - liofilizat za suspenziju - imunološki vmp - kokoši i purana
sotalol/mylan tab 80mg/tab
mylan ireland limited, ireland unit 35/36 grange parade, - dublin 13 - sotalol hydrochloride - tab (ΔΙΣΚΙΟ) - 80mg/tab - sotalol hydrochloride 80mg - sotalol
sotalol/mylan tab 160mg/tab
mylan ireland limited, ireland unit 35/36 grange parade, - dublin 13 - sotalol hydrochloride - tab (ΔΙΣΚΙΟ) - 160mg/tab - sotalol hydrochloride 160mg - sotalol
sotalex 160 mg tabl.
cheplapharm arzneimittel gmbh - sotalolhydrochloride 160 mg - tablet - 160 mg - sotalolhydrochloride 160 mg - sotalol
sotalol viatris 160 mg tabl.
viatris gx bv-srl - sotalolhydrochloride 160 mg - tablet - 160 mg - sotalolhydrochloride 160 mg - sotalol
sotalol mylan 160 mg tablett
mylan ab - sotalolhydroklorid - tablett - 160 mg - sotalolhydroklorid 160 mg aktiv substans - sotalol
sotalol 2care4 160 mg tablett
2care4 aps - sotalolhydroklorid - tablett - 160 mg - sotalolhydroklorid 160 mg aktiv substans - sotalol